Physician profile

Esther Bae

Vascular Surgery · Burlingame, CA

NPI 1609147453

$26,309.35

in general payments reported to CMS, 2019-2025

34 companies · $7,815 in 2025

The $7,815 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$6,969.62
Food and Beverage$5,310.97
Education$35.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $7,851.55 2019
Penumbra, INC. $6,773.20 2021-2025 Indigo System, Ruby Coil
Nuvasive, INC. $1,716.61 2023 Alif
W. L. Gore & Associates, INC. $1,706.53 2021-2025 Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis
Alphatec Spine, INC $958.74 2025 Other - Miscellaneous
Bard Peripheral Vascular, INC. $917.54 2019-2023 Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon
Medtronic, INC. $710.30 2021-2025 Endurant Iis
Cook Medical LLC $645.67 2019-2025 Zilver Ptx
Silk Road Medical, INC. $535.64 2022-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Globus Medical, INC. $495.00 2019
Inari Medical, INC. $461.38 2019-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Boston Scientific Corporation $440.46 2023-2025 Enroute Transcarotid Neuroprotection System, Varithena Administration Pack, Ranger
Smith+Nephew, INC. $412.91 2021-2024 Grafix, Oasis, Stravix
Kci USA, INC. $400.00 2019
Kerecis Limited $377.32 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Philips North America LLC $192.12 2021-2022
Bolton Medical INC $190.09 2019-2024 Relay Thoracic Stent-Graft With Plus Delivery System
Janssen Pharmaceuticals, INC $186.81 2021-2022
Stryker Corporation $175.81 2025 Flowtriever
Surmodics, INC. $139.93 2024 Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight
Veryan Medical Incorporated $131.48 2022
Cordis US Corp. $127.69 2024 Mynx Control
Shockwave Medical, INC $119.74 2022
Terumo Medical Corporation $119.54 2023 Azur Cx Detachable
Organogenesis INC. $109.70 2024 Puraply Wound Matrix
Endologix LLC $106.94 2020
Hydrofera LLC $95.00 2021
Intuitive Surgical, INC. $76.78 2022
Astrazeneca Pharmaceuticals LP $35.06 2025 Imfinzi
Tactile Systems Technology INC $28.32 2021
Aroa Biosurgery Incorporated $24.16 2023
Lemaitre Vascular, INC. $22.00 2022
Melinta Therapeutics, LLC $14.36 2022
Cardiovascular Systems INC. $10.97 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Esther Bae

$26,309.35

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic Vascular, INC.
Context
The $7,815 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/1391348/esther-bae

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.